Ureteral necrosis after kidney transplantation: Risk factors and impact on graft and patient survival

Transplantation

Volumn 78, Issue 5, 2004, Pages 725-729

  Karam, Georges ^a   Maillet, Frédéric ^a   Parant, Sophie ^a   Soulillou, Jean Paul ^b   Giral Classe, Magali ^b  

^a HÔTEL DIEU   (France)

^b Inst Transplant/Rech Transplant   (France)

Author keywords

Cytomegalovirus; Delayed graft function; Donor age; Kidney; Transplantation; Ureteral necrosis; Urinary fistula

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; VALACICLOVIR;

ACUTE PYELONEPHRITIS; ADULT; ANTIGEN ANTIBODY REACTION; ARTERY THROMBOSIS; ARTICLE; BK VIRUS; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DEATH; FEMALE; GENDER; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LEUKOCYTE; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NECROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENAL ARTERY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; URETER DISEASE; URETER STENT; URETERAL NECROSIS; URETERONEOCYSTOSTOMY; VALIDATION PROCESS; VEIN THROMBOSIS; VIRUS INCLUSION; VIRUS INFECTION;

ADULT; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; NECROSIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; URETER;

EID: 4544294483     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000131953.13414.99     Document Type: Article

References (20)

1. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994; 331: 365.
2. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
3. Gogus C, Yaman O, Soygur T, et al. Urological complications in renal transplantation: Long-term follow-up of the Woodruff ureteroneocystostomy procedure in 433 patients. Urol Int 2002; 69: 99.
4. Secin FP, Rovegno AR, Marrugat RE, et al. Comparing Taguchi and Lich-Gregoir ureterovesical reimplantation techniques for kidney transplants. J Urol 2002; 168: 926.
5. Nicol DL, P'Ng K, Hardie DR, et al. Routine use of indwelling ureteral stents in renal transplantation. J Urol 1993; 150: 1375.
6. Shoskes DA, Hanbury D, Cranston D, et al. Urological complications in 1,000 consecutive renal transplant recipients. J Urol 1995; 153: 18.
7. Giral-Classe M, Hourmant M, Cantarovich D, et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998; 54: 972.
8. Giral M, Pascuariello G, Karam G, et al. Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int 2002; 61: 1880.
9. Giral M, Taddei C, Nguyen JM, et al. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy. Clin Transpl 1996; 257.
10. Soulillou JP, Cantarovich D, Le MB, et al. Randomized controlled trial of a monoclonal antibody against the interieukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 1990; 322: 1175.
11. Nashan B, Moore R, Amlot P, et al. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients: CHIB 201 International Study Group. Lancet 1997; 350: 1193.
12. Nane I, Kadioglu TC, Tefekli A, et al. Urologic complications of extravesical ureteroneocystostomy in renal transplantation from living related donors. Urol Int 2000; 64: 27.
13. Shaul DB, Xie HW, Shimada H, et al. Venous ischemia as a cause of ureteral necrosis in transplanted ureters. J Pediatr Surg 1999; 34: 1725.
14. Lowell JA, Stratta RJ, Morton JJ, et al. Invasive cytomegalovirus infection in a renal transplant ureter after combined pancreas-kidney transplantation: An unusual cause of renal allograft dysfunction. J Urol 1994; 152: 1546.
15. Moudgil A, Germain BM, Nast CC, et al. Ureteritis and cholecystitis: Two unusual manifestations of cytomegalovirus disease in renal transplant recipients. Transplantation 1997; 64: 1071.
16. Mateo R, Vivas C, Shapiro R, et al. Cytomegalovirus infection of the native ureter after liver-kidney transplantation. Urology 1999; 54: 366.
17. Peretti N, Said MH, Bouvier R, et al. Cytomegalovirus infection may cause ureteral necrosis. Transplantation 2000; 69: 670.
18. Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91: 119.
19. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106: 145.
20. Giral M, Nguyen JM, Daguin P, et al. Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction. J Am Soc Nephrol 2001; 12: 1758.